The process varies by insurer, but the general steps are consistent: request the denial in writing (the insurer must provide the specific reason), have your prescriber write a letter of medical necessity that addresses the denial reason directly, include supporting clinical data (STEP, SURMOUNT, SELECT trial results), and submit within the appeal deadline (typically 60 to 180 days depending on the plan)
GLP-1R activation leads to a rapid increase in the levels of cyclic adenosine monophosphate (AMP) and intracellular calcium followed by glucose-dependent insulin release
In parallel, we released a companion report that uses dispense data to examine switching patterns during the same period as the CVS formulary change, providing a complementary perspective on how patients transitioned between GLP-1 RAs
Common side effects of GLP-1 agonists include gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain
However, results can vary from person to person, and its essential to work closely with a healthcare provider to tailor the treatment to your unique needs and goals for safe and sustainable weight loss
There's a Wegovy Pregnancy Registry to help doctors understand the safety of weight-loss medication use during pregnancy